Live Oak Private Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,281
Closed -$201K 165
2023
Q2
$201K Buy
+2,281
New +$196K 0.04% 154
2022
Q4
Sell
-3,635
Closed -$294K 176
2022
Q3
$294K Sell
3,635
-18,391
-83% -$1.65M 0.07% 133
2022
Q2
$1.98M Buy
22,026
+2,517
+13% +$255K 0.42% 67
2022
Q1
$2.16M Buy
19,509
+6,002
+44% +$634K 0.42% 65
2021
Q4
$1.4M Buy
13,507
+1,795
+15% +$208K 0.26% 79
2021
Q3
$1.47M Buy
11,712
+2,348
+25% +$304K 0.3% 76
2021
Q2
$1.16M Buy
9,364
+961
+11% +$121K 0.26% 80
2021
Q1
$993K Buy
8,403
+2,199
+35% +$258K 0.24% 78
2020
Q4
$727K Buy
6,204
+986
+19% +$109K 0.2% 82
2020
Q3
$542K Buy
5,218
+851
+19% +$85.5K 0.19% 84
2020
Q2
$400K Buy
4,367
+481
+12% +$46.1K 0.15% 95
2020
Q1
$350K Buy
3,886
+1,094
+39% +$116K 0.36% 49
2019
Q4
$317K Buy
+2,792
New +$306K 0.31% 53

Other funds holding MDT

Live Oak Private Wealth's MDT Position: Q3 2023 in Review

Live Oak Private Wealth sold out of Medtronic (MDT) in Q3 2023, closing a stake of 2,281 shares — an estimated $201K sold.

Live Oak Private Wealth first reported a position in MDT in Q4 2019 and held it in 13 quarters. The position peaked at $2.16M in Q1 2022. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Live Oak Private Wealth reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Live Oak Private Wealth sold 2,281 Medtronic shares in Q3 2023, an estimated $201K.
  • Live Oak Private Wealth first reported a position in Medtronic in Q4 2019 and held it in 13 quarters.
  • Live Oak Private Wealth's Medtronic position peaked at $2.16M in Q1 2022.
  • 1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Live Oak Private Wealth's 13F filing for Q3 2023, filed 23 Oct 2023.